These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 16998755)

  • 61. [Fisher syndrome and Bickerstaff brainstem encephalitis].
    Kuwabara S
    Rinsho Shinkeigaku; 2014; 54(12):1056-7. PubMed ID: 25672708
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Early platelet and leukocyte decline in patients with neuroinflammatory disorders after intravenous immunoglobulins.
    Totzeck A; Stettner M; Hagenacker T
    Eur J Neurol; 2017 Apr; 24(4):638-644. PubMed ID: 28224702
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Immunotherapy of intravenous immunoglobulin preparations in neurologic diseases].
    Lewańska M; Selmaj K
    Postepy Hig Med Dosw; 2002; 56 Suppl():69-83. PubMed ID: 12661417
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Childhood acute and chronic immune-mediated polyradiculoneuropathies.
    Rabie M; Nevo Y
    Eur J Paediatr Neurol; 2009 May; 13(3):209-18. PubMed ID: 18585069
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Quality of life in inflammatory neuropathies: the IN-QoL.
    Draak THP; Faber CG; Merkies ISJ;
    J Neurol Neurosurg Psychiatry; 2018 Mar; 89(3):256-262. PubMed ID: 28986470
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical immunopharmacology of autoimmune neuropathies and myopathies.
    Gordon AJ; Meriggioli MN
    Clin Neuropharmacol; 2002; 25(3):174-81. PubMed ID: 12023571
    [No Abstract]   [Full Text] [Related]  

  • 67. [Treatment of chronic inflammatory polyradiculoneuropathy].
    Nicolas G
    Rev Med Interne; 2008 Jun; 29 Spec No 2():1-8. PubMed ID: 18927988
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Plasma exchange and intravenous immunoglobulins: mechanism of action in immune-mediated neuropathies.
    Lehmann HC; Hartung HP
    J Neuroimmunol; 2011 Feb; 231(1-2):61-9. PubMed ID: 21056913
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) associated to hereditary neuropathy with liability to pressure palsies (HNPP) and revealed after influenza AH1N1 vaccination.
    Remiche G; Abramowicz M; Mavroudakis N
    Acta Neurol Belg; 2013 Dec; 113(4):519-22. PubMed ID: 24146347
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Dendritic cells in the cerebrospinal fluid and peripheral nerves in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
    Press R; Nennesmo I; Kouwenhoven M; Huang YM; Link H; Pashenkov M
    J Neuroimmunol; 2005 Feb; 159(1-2):165-76. PubMed ID: 15652416
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Immune mechanisms, the role of complement, and related therapies in autoimmune neuropathies.
    Latov N
    Expert Rev Clin Immunol; 2021 Dec; 17(12):1269-1281. PubMed ID: 34751638
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pathogenesis of immune-mediated neuropathies.
    Dalakas MC
    Biochim Biophys Acta; 2015 Apr; 1852(4):658-66. PubMed ID: 24949885
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Dysimmune neuropathies: current diagnosis and therapy].
    Léger JM; Larue S; Dashi F
    Rev Prat; 2008 Nov; 58(17):1887-9, 1892-4. PubMed ID: 19157204
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Electrophysiological diagnosis of inflammatory neuropathies].
    Petiot P
    Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S36-44. PubMed ID: 18087228
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Guillain-Barré syndrome: rare extra-intestinal manifestation of hepatitis B.
    Sonavane AD; Saigal S; Kathuria A; Choudhary NS; Saraf N
    Clin J Gastroenterol; 2018 Aug; 11(4):312-314. PubMed ID: 29542024
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Intravenous immunoglobulin treatment in multifocal motor neuropathy and other chronic immune-mediated neuropathies.
    Comi G; Nemni R; Amadio S; Galardi G; Leocani L
    Mult Scler; 1997 Apr; 3(2):93-7. PubMed ID: 9291161
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Use of intravenous immunoglobulin in neurological disorders].
    Steck AJ
    Rev Med Suisse; 2005 Apr; 1(17):1167-70. PubMed ID: 15941089
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Guillain-Barré syndrome.
    Ansar V; Valadi N
    Prim Care; 2015 Jun; 42(2):189-93. PubMed ID: 25979580
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin-1 autoantibodies.
    Doppler K; Appeltshauser L; Wilhelmi K; Villmann C; Dib-Hajj SD; Waxman SG; Mäurer M; Weishaupt A; Sommer C
    J Neurol Neurosurg Psychiatry; 2015 Jul; 86(7):720-8. PubMed ID: 25694474
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Plasmacytosis is a common immune signature in patients with MMN and CIDP and responds to treatment with IVIg.
    Korporal-Kuhnke M; Haas J; Schwarz A; Jarius S; Wildemann B
    J Neuroimmunol; 2015 Jan; 278():60-8. PubMed ID: 25595253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.